Search

Your search keyword '"Campbell, Gabrielle"' showing total 355 results
Start Over Author "Campbell, Gabrielle"
355 results on '"Campbell, Gabrielle"'

10. 'We didn't cause the opioid epidemic': The experiences of Australians prescribed opioids for chronic non‐cancer pain at a time of increasing restrictions.

Author

Hopkins, Ria E., Campbell, Gabrielle, Degenhardt, Louisa, and Gisev, Natasa

Subjects
*OPIOID epidemic, *PAIN management, *CHRONIC pain, *THEMATIC analysis, *OPIOIDS, *CANCER pain
Abstract

Introduction: Many countries have implemented strategies to reduce opioid‐related harms, including policies and prescribing restrictions. This study aimed to explore the lived experiences of Australians prescribed opioids for chronic non‐cancer pain (CNCP) in the context of increasing restrictions for accessing opioids. Methods: Semi‐structured interviews were conducted with 14 Australians (aged 24–65‐years; 10 female/4 male) self‐reporting regular use of prescribed opioids for CNCP. Participants were asked to describe their experiences using prescribed opioids, and perceived and actual changes in pain management including access to treatments. Using thematic analysis, four dominant themes were identified. Results: In 'On them for a reason': Opioids as a last resort, participants described the role of opioids as an important tool for pain management following unsuccessful treatment using other strategies. In 'You're problematic': Deepening stigma, participants described how increased attention and restrictions led to increasing stigma of opioid use and CNCP. In 'We didn't cause the opioid epidemic': Perceiving and redirecting blame, participants described feeling unfairly blamed for public health problems and an 'opioid epidemic' they described as 'imported' from America, drawing distinctions between legitimate and illegitimate opioid use. Finally, in 'Where do we go from here?': Fearing the future, participants described anticipating further restrictions and associating these with increased pain and disability. Discussion and Conclusions: The experience of being prescribed opioids for CNCP in Australia in the context of increasing restrictions was characterised by stigma, blame and fear. There is a need to ensure people prescribed opioids for pain are considered when designing measures to reduce opioid‐related harms. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

17. Clinical Observation, Management and Function Of low back pain Relief Therapies (COMFORT): A cluster randomised controlled trial protocol

Author

Abdel Shaheed, Christina, primary, Ivers, Rowena, additional, Vizza, Lisa, additional, McLachlan, Andrew, additional, Kelly, Patrick J, additional, Blyth, Fiona, additional, Stanaway, Fiona, additional, Clare, Philip James, additional, Thompson, Rachel, additional, Lung, Thomas, additional, Degenhardt, Louisa, additional, Reid, Sharon, additional, Martin, Bradley, additional, Wright, Michael, additional, Osman, Rawa, additional, French, Simon, additional, McCaffery, Kirsten, additional, Campbell, Gabrielle, additional, Jenkins, Hazel, additional, Mathieson, Stephanie, additional, Boogs, Monika, additional, McMaugh, Jarrod, additional, Bennett, Carol, additional, and Maher, Christopher, additional

Published
2023
Full Text
View/download PDF

30. Commentary on Yang et al.: The need for a renewed focus on identifying and responding to chronic pain among people with substance use disorders.

Author

Campbell, Gabrielle and Larance, Briony

Subjects
*SUBSTANCE abuse, *PAIN measurement, *CHRONIC pain, *OPIOID analgesics, *PAIN management
Abstract

The authors comment on a study by J. Yang and colleagues which provided estimates of the prevalence of current pain and chronic pain among the specific group of people seeking or receiving opioid agonist treatment (OAT). Topics include association between chronic pain and a greater risk of unemployment and more severe mental health symptoms compared to people without chronic pain and barriers that are probably greater among people entering treatment for substance use disorders.

Published
2024
Full Text
View/download PDF

36. Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence

Author

Santo, Thomas, primary, Clark, Brodie, additional, Hickman, Matt, additional, Grebely, Jason, additional, Campbell, Gabrielle, additional, Sordo, Luis, additional, Chen, Aileen, additional, Tran, Lucy Thi, additional, Bharat, Chrianna, additional, Padmanathan, Prianka, additional, Cousins, Grainne, additional, Dupouy, Julie, additional, Kelty, Erin, additional, Muga, Roberto, additional, Nosyk, Bohdan, additional, Min, Jeong, additional, Pavarin, Raimondo, additional, Farrell, Michael, additional, and Degenhardt, Louisa, additional

Published
2021
Full Text
View/download PDF

37. LONGER TERM OUTCOMES FOR PHARMACEUTICAL OPIOID DEPENDENCE: 12 MONTH FINDINGS FROM AN IN-TREATMENT COHORT: Paper 30

Author

NIELSEN, SUZANNE, LARANCE, BRIONY, LINTZERIS, NICHOLAS, HOLLIDAY, SIMON, VANDERHAVEN, MICHAEL, HORDERN, ANTONIA, DUNLOP, ADRIAN, HABER, PAUL S., MURNION, BRIDIN, SILSBURY, CATHERINE, JOHNSON, JENNIFER, DEMIRKOL, APO, SADLER, CRAIG, PHUNG, NGHI, CAMPBELL, GABRIELLE, FARRELL, MICHAEL, COHEN, MILTON, BRUNO, RAIMONDO, HARDY, MARK, BROWN, AMANDA, HOUSEMAN, JENNIE, and DEGENHARDT, LOUISA

Published
2015

45. Crime, drugs and distress: patterns of drug use and harm among criminally involved injecting drug users in Australia

Author

Kinner, Stuart A., George, Jessica, Campbell, Gabrielle, and Degenhardt, Louisa

Subjects
Intravenous drug abuse -- Demographic aspects, Intravenous drug abuse -- Psychological aspects, Intravenous drug abuse -- Social aspects, Criminal behavior -- Research, Health
Abstract

Objective: Explore demographic characteristics, patterns of drug use and psychological distress among regular injecting drug users (IDUs) in Australia, as a function of recent criminal activity. Methods: Structured, face-to-face interviews with 909 regular IDUs recruited from every capital city in Australia, between June and August 2007, as part of the annual Illicit Drug Reporting System (IDRS). Criminal activity in the past month was assessed using the Opiate Treatment Index (OTI); psychological distress was assessed using the Kessler psychological distress scale (K10). Results: Forty-three per cent of IDUs reported recent (past month) criminal activity. Those who had committed crime recently were younger, exhibited riskier patterns of drug use, reported more drug-related problems and were more likely to exhibit significant psychological distress. In a multivariate model the most important correlates of recent criminal activity were use of more than three drug types recently (OR=2.66, 95% CI 1.96-3.61), initiation to injecting before age 18 (OR=1.93, 95% CI 1.42-2.61) and daily drug injection (OR=1.55, 95% CI 1.13-2.13). Conclusions and Implications: Criminal activity among regular IDUs in Australia is not restricted to a particular demographic group, and is a marker for riskier patterns of drug use, greater drug-related harm and psychological distress. Contact between IDUs and the criminal justice system provides opportunities for the delivery of targeted harm reduction messages, and for screening and diversion into appropriate treatment services. Key words: crime, substance abuse, intravenous, mental health, harm reduction. doi: 10.1111/j.1753-6405.2009.00379.x

Published
2009

46. Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018

Author

Degenhardt, Louisa, primary, Hungerford, Phillip, additional, Nielsen, Suzanne, additional, Bruno, Raimondo, additional, Larance, Briony, additional, Clare, Philip J., additional, Dobbins, Timothy, additional, Hall, Wayne, additional, Cohen, Milton, additional, Blyth, Fiona, additional, Lintzeris, Nicholas, additional, Farrell, Michael, additional, and Campbell, Gabrielle, additional

Published
2021
Full Text
View/download PDF

47. Quantifying the social costs of pharmaceutical opioid misuse and illicit opioid use to Australia in 2015/16

Author

Makate, Marshall, Whetton, Steve, Tait, Robert, Chrzanowska,, Agata, Donnelly, Neil, McEntee, Alice, Muhktar, Aqif, Zahra, Emma, Campbell, Gabrielle, Degenhardt, Louisa, Dey, Tania, Halim, Suraya Abdul, Hall, Wayne, Norman, Richard, Peacok, Amy, Roche, Ann, Allsop, Steve, Makate, Marshall, Whetton, Steve, Tait, Robert, Chrzanowska,, Agata, Donnelly, Neil, McEntee, Alice, Muhktar, Aqif, Zahra, Emma, Campbell, Gabrielle, Degenhardt, Louisa, Dey, Tania, Halim, Suraya Abdul, Hall, Wayne, Norman, Richard, Peacok, Amy, Roche, Ann, and Allsop, Steve

Abstract

In recent decades the range and patterns of opioids used for extra-medical purposes have changed. The use of pharmaceutical opioids exceeds the use of heroin. In 2017, 63 percent of opioid deaths were attributed exclusively to pharmaceutical opioids, 28 percent to illicit opioids and 8 percent to both illicit and pharmaceutical opioids (aged 15-64 years). The objective of this report was to estimate the social costs arising from extra-medical opioid use in Australia for the financial year 2015/16. Due to data limitations in most cases we only estimated the costs occurring in this 12 month period. For example, on-going care of chronic conditions was not included. The exceptions to this were for certain harms which occurred in 2015/16 but which had longer-term ramifications, for example premature deaths, where discounted streams of future costs (lost economic activity and lost contributions to household chores) and partially offsetting savings (future health expenditure ’avoided’ by premature deaths) were estimated. The authors also included the long-term costs of road traffic accidents, as were the expected future costs of opioid attributable imprisonment for those sentenced in 2015/16.

Published
2020

48. Development of a Brief Patient-Administered Screening Tool for Prescription Opioid Dependence for Primary Care Settings

Author

Nielsen, Suzanne, Picco, Louisa, Campbell, Gabrielle, Lintzeris, Nicholas, Larance, Briony K, Farrell, Michael, Degenhardt, Louisa, Bruno, Raimondo, Nielsen, Suzanne, Picco, Louisa, Campbell, Gabrielle, Lintzeris, Nicholas, Larance, Briony K, Farrell, Michael, Degenhardt, Louisa, and Bruno, Raimondo

Abstract

2019 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. OBJECTIVE: To develop a short, patient-administered screening tool that will allow for earlier assessment of prescription opioid dependence (often referred to as addiction) in primary care settings. DESIGN AND SETTING: Cross-sectional analysis (N = 1,134) from the two-year time point of the Pain and Opioids IN Treatment (POINT) cohort was used in the scale development. SUBJECTS: Participants who completed two-year interviews in the POINT study, a prospective cohort study that followed people with chronic noncancer pain over a five-year period, and who were prescribed strong opioids for a minimum of six weeks at baseline. METHODS: An advisory committee provided advice on wording and content for screening in primary care settings. Univariate logistic regression identified individual items that were significantly associated with meeting ICD-11 criteria for prescription opioid dependence. Exploratory and confirmatory factor analysis (EFA and CFA) were conducted, and items were reduced to identify a small item set that were discriminative and shared a simple underlying structure. RESULTS: Sixty-four variables associated with ICD-11 criteria for prescription opioid dependence were initially identified. Four rounds of EFA were performed, resulting in five items remaining. CFA identified two possible four-item combinations, with the final combination chosen based on greater item endorsement and the results of goodness-of-fit indices. CONCLUSIONS: Addressing prescription opioid dependence is an important part of the global public health challenge surrounding rising opioid-related harm. This study addresses an important initial requisite step to develop a brief screening tool. Further studies are required to validate the tool in clinical settings.

Published
2020

49. Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non‐cancer pain: A five‐year prospective cohort study

Author

Nielsen, Suzanne, primary, Gisev, Natasa, additional, Leung, Janni, additional, Clare, Philip, additional, Bruno, Raimondo, additional, Lintzeris, Nicholas, additional, Larance, Briony, additional, Blyth, Fiona, additional, Hall, Wayne, additional, Cohen, Milton, additional, Degenhardt, Louisa, additional, Farrell, Michael, additional, and Campbell, Gabrielle, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results